G. Thal

发表

Immunological characterization of the major chick cartilage proteoglycan and its intracellular localization in cultured chondroblasts: a comparison with Type II procollagen

D. Boettiger, M. Pacifici, H. Holtzer, 1983, The Journal of cell biology.

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.

J. Mellors, J. Coffin, S. Swindells, 2009, The Journal of infectious diseases.

Exacerbation or Unmasking of Focal Neurologic Deficits by Sedatives

G. Crosby, M. Lopez-Bresnahan, M. Szabo, 1996, Anesthesiology.

Immunological analysis of chick notochord and cartilage matrix development with antisera to cartilage matrix macromolecules.

M. Pacifici, H. Holtzer, J. Sasse, 1985, Developmental biology.

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.

J. Mellors, S. Swindells, A. DiRienzo, 2006, JAMA.

Differential survival of cartilage and muscle cells in chick limb-bud cell cultures maintained in chemically defined and serum-containing media.

M. Pacifici, H. Holtzer, J. Sasse, 1986, Differentiation; research in biological diversity.

Pharmacodynamics of Vecuronium and Atracurium in the Obese Surgical Patient

R. Matteo, E. Ornstein, J. Weinstein, 1988, Anesthesia and analgesia.

Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)

J. Absalon, M. Mancini, R. Yang, 2008 .

Acute, subacute, and chronic histologic effects of simulated aspiration of a 0.7% sucralfate suspension in rats.

J. Leiter, K. E. Shepherd, C. Faulkner, 1995, Critical care medicine.

The Association of Tacrolimus Formulation Switching with Trough Concentration Variability: A Retrospective Cohort Study of Tacrolimus Use Post-Kidney Transplantation Based on National Drug Code (NDC) Numbers

W. Irish, B. Franks, J. Schwartz, 2019, Advances in Therapy.

THE EFFECTS OF TAXOL ON CHONDROBLAST PROTEOGLYCAN SECRETION

M. Pacifici, H. Holtzer, R. Soltesz, 1982 .

Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.

C. Farthing, A. Zolopa, J. Gallant, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Further information on the administration of h2-receptor antagonists with atazanavir.

R. Bertz, R. Nettles, S. Agarwala, 2006, Journal of acquired immune deficiency syndromes.